Does LEVOMILNACIPRAN Cause Intentional product use issue? 139 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 139 reports of Intentional product use issue have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 10.1% of all adverse event reports for LEVOMILNACIPRAN.
139
Reports of Intentional product use issue with LEVOMILNACIPRAN
10.1%
of all LEVOMILNACIPRAN reports
137
Deaths
82
Hospitalizations
How Dangerous Is Intentional product use issue From LEVOMILNACIPRAN?
Of the 139 reports, 137 (98.6%) resulted in death, 82 (59.0%) required hospitalization, and 83 (59.7%) were considered life-threatening.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 139 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Off label use (376)
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which LEVOMILNACIPRAN Alternatives Have Lower Intentional product use issue Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE